These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31190595)
1. Development of liposome as a novel adsorbent for artificial liver support system in liver failure. Shen Y; Wang Y; Shi Y; Tian H; Zhu Q; Ding F J Liposome Res; 2020 Sep; 30(3):246-254. PubMed ID: 31190595 [TBL] [Abstract][Full Text] [Related]
2. Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial. Wallon G; Guth C; Guichon C; Thevenon S; Gazon M; Viale JP; Schoeffler M; Duperret S; Aubrun F Blood Purif; 2022; 51(3):243-250. PubMed ID: 34139706 [TBL] [Abstract][Full Text] [Related]
3. Linoleic acid-modified liposomes for the removal of protein-bound toxins: An in vitro study. Shen Y; Shen Y; Bi X; Li J; Chen Y; Zhu Q; Wang Y; Ding F Int J Artif Organs; 2021 Jun; 44(6):393-403. PubMed ID: 33135543 [TBL] [Abstract][Full Text] [Related]
4. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264 [TBL] [Abstract][Full Text] [Related]
5. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study. Sponholz C; Matthes K; Rupp D; Backaus W; Klammt S; Karailieva D; Bauschke A; Settmacher U; Kohl M; Clemens MG; Mitzner S; Bauer M; Kortgen A Crit Care; 2016 Jan; 20():2. PubMed ID: 26728364 [TBL] [Abstract][Full Text] [Related]
6. Review of methods to remove protein-bound substances in liver failure. Hughes RD Int J Artif Organs; 2002 Oct; 25(10):911-7. PubMed ID: 12456030 [TBL] [Abstract][Full Text] [Related]
7. Albumin dialysis: single pass vs. recirculation (MARS). Peszynski P; Klammt S; Peters E; Mitzner S; Stange J; Schmidt R Liver; 2002; 22 Suppl 2():40-2. PubMed ID: 12220302 [TBL] [Abstract][Full Text] [Related]
8. Clearing of toxic substances: are there differences between the available liver support devices? Krisper P; Stadlbauer V; Stauber RE Liver Int; 2011 Sep; 31 Suppl 3():5-8. PubMed ID: 21824275 [TBL] [Abstract][Full Text] [Related]
9. Significant decrease in dialysate albumin concentration during molecular adsorbent recirculating system (M.A.R.S.) therapy. Gong D; Ji D; Ren B; Tao J; Xu B; Ronco C; Li L Int J Artif Organs; 2008 Apr; 31(4):333-9. PubMed ID: 18432590 [TBL] [Abstract][Full Text] [Related]
10. [A pilot study of using pure albumin as a dialysate in the treatment of liver failure]. Liu Q; Peng L; Du Y; Li M; Jia N; Zou HQ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):599-602. PubMed ID: 16259917 [TBL] [Abstract][Full Text] [Related]
11. Albumin dialysis molecular adsorbents recirculating system: impact of dialysate albumin concentration on detoxification efficacy. Drexler K; Baustian C; Richter G; Ludwig J; Ramlow W; Mitzner S Ther Apher Dial; 2009 Oct; 13(5):393-8. PubMed ID: 19788455 [TBL] [Abstract][Full Text] [Related]
12. Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure. Evenepoel P; Laleman W; Wilmer A; Claes K; Maes B; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y Blood Purif; 2005; 23(5):349-58. PubMed ID: 16020951 [TBL] [Abstract][Full Text] [Related]
13. Targeting Albumin Binding Function as a Therapy Goal in Liver Failure: Development of a Novel Adsorbent for Albumin Dialysis. Dominik A; Stange J; Baumann AK; Pfensig C; Suraj M; Ibrahim B; Eggert M Ther Apher Dial; 2018 Apr; 22(2):196-204. PubMed ID: 29266788 [TBL] [Abstract][Full Text] [Related]
14. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Klammt S; Mitzner SR; Stange J; Loock J; Heemann U; Emmrich J; Reisinger EC; Schmidt R Liver Transpl; 2008 Sep; 14(9):1333-9. PubMed ID: 18756471 [TBL] [Abstract][Full Text] [Related]
15. Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure. Di Campli C; Zileri Dal Verme L; Andrisani MC; Armuzzi A; Candelli M; Gaspari R; Gasbarrini A Curr Med Chem; 2003 Feb; 10(4):341-8. PubMed ID: 12570706 [TBL] [Abstract][Full Text] [Related]
16. [Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters]. Mitzner S; Klammt S; Stange J; Nöldge-Schomburg GF; Schmidt R Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):199-206. PubMed ID: 15832238 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin. Awad SS; Rich PB; Kolla S; Younger JG; Reickert CA; Downing VP; Bartlett RH ASAIO J; 1997; 43(5):M745-9. PubMed ID: 9360145 [TBL] [Abstract][Full Text] [Related]
19. Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin. Lee KH; Wendon J; Lee M; Da Costa M; Lim SG; Tan KC Liver Transpl; 2002 Jul; 8(7):591-3. PubMed ID: 12089711 [TBL] [Abstract][Full Text] [Related]
20. Superior Dialytic Removal of Bilirubin and Bile Acids by Free Fatty Acid Displacement and Its Synergy With Albumin-Based Dialysis. Shi Y; Wang Y; Shen Y; Zhu Q; Ding F ASAIO J; 2023 Jan; 69(1):127-135. PubMed ID: 35412475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]